Colgate Palmolive Co (CL) KPIs and segments
Close on Nov 17, 2026Market cap $79.18BP/E 39.1Yield 2.09%
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Colgate Palmolive · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Colgate Palmolive: 74 chỉ số vận hành, trong đó có Global Toothpaste Market Share, Year-to-Date, Global Manual Toothbrush Market Share, Year-to-Date và Worldwide Net Sales Mix by Product Category, lấy từ 192 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oral, Personal and Home Care($M)6 | 4,164 | 4,166 | 4,131 | 4,034 | 3,989 | 3,954 | 3,792 | 3,804 | 3,907 | 3,944 | 3,963 | 3,835 | |
Latin America($M) | 1,326 | 1,372 | 1,313 | 1,248 | 1,178 | 1,207 | 1,143 | 1,106 | 1,156 | 1,267 | 1,253 | 1,193 | |
Europe, Middle East & Africa($M) | 1,130 | 1,121 | 1,126 | 1,115 | 1,083 | 1,007 | |||||||
North America($M) | 905 | 891 | 888 | 1,300 | 922 | 919 | 904 | 1,037 | 1,004 | 1,037 | 1,035 | 1,047 | |
Asia Pacific($M) | 802 | 782 | 804 | 555 | 775 | 746 | 738 | 725 | 725 | 682 | 727 | 698 | |
Europe($M) | 734 | 801 | 738 | 690 | 668 | 744 | 685 | 673 | 636 | ||||
Africa/Eurasia($M) | 309 | 297 | 295 | 271 | 268 | 278 | 273 | 276 | 261 | ||||
Hill's Pet Nutrition($M) | 1,205 | 1,195 | 1,194 | 1,142 | 1,157 | 1,118 | |||||||
Pet Nutrition($M) | 1,196 | 1,142 | 1,157 | 1,118 | 1,141 | 1,126 | 1,114 | 1,102 | 1,115 | ||||
Oral, Personal and Home Care($M) | 1,042 | 1,082 | 1,030 | 998 | 992 | 997 | 971 | 969 | 1,016 | 1,058 | 1,044 | 1,009 | |
Pet Nutrition($M) | 286 | 255 | 264 | 258 | 274 | 258 | 235 | 199 | 231 | ||||
Hill's Pet Nutrition($M) | 267 | 269 | 280 | 255 | 264 | 258 | |||||||
Latin America($M) | 392 | 418 | 401 | 359 | 337 | 367 | 348 | 339 | 365 | 417 | 405 | 367 | |
Europe, Middle East & Africa($M) | 262 | 263 | 266 | 243 | 241 | 222 | |||||||
Asia Pacific($M) | 211 | 209 | 222 | 140 | 213 | 202 | 204 | 210 | 199 | 195 | 207 | 203 | |
Europe($M) | 182 | 209 | 184 | 172 | 156 | 181 | 169 | 153 | 151 | ||||
North America($M) | 177 | 192 | 141 | 201 | 199 | 187 | 197 | 206 | 206 | 213 | 214 | 231 | |
Africa/Eurasia($M) | 65 | 68 | 65 | 57 | 58 | 65 | 64 | 66 | 58 | ||||
Hill's Pet Nutrition($M) | 744 | 747 | 739 | 685 | 695 | 681 | |||||||
Pet Nutrition($M) | 734 | 685 | 695 | 681 | 676 | 663 | 655 | 620 | |||||
Latin America($M) | 756 | 789 | 759 | 696 | 637 | 680 | 656 | 637 | 697 | 763 | 751 | ||
Europe, Middle East & Africa($M) | 712 | 716 | 718 | 698 | 688 | 640 | |||||||
North America($M) | 524 | 551 | 498 | 830 | 541 | 539 | 546 | 632 | 623 | 641 | 645 | ||
Asia Pacific($M) | 502 | 491 | 509 | 335 | 487 | 462 | 463 | 461 | 456 | 422 | 443 | ||
Europe($M) | 467 | 501 | 463 | 432 | 419 | 469 | 427 | 406 | |||||
Africa/Eurasia($M) | 183 | 179 | 178 | 167 | 155 | 169 | 168 | 170 | |||||
Hill's Pet Nutrition($M) | -23 | -15 | -22 | -21 | -22 | -21 | |||||||
Pet Nutrition($M) | -24 | -21 | -22 | -21 | -35 | -24 | -31 | -53 | |||||
Oral, Personal and Home Care($M) | -85 | -90 | -77 | -122 | -103 | -68 | -68 | -127 | -81 | -62 | -47 | ||
Africa/Eurasia($M) | -4 | -4 | -2 | -2 | -6 | -3 | -1 | -1 | |||||
Europe, Middle East & Africa($M) | -12 | -16 | -10 | -22 | -15 | -11 | |||||||
North America($M) | -13 | -18 | -14 | -19 | -17 | -13 | -16 | -22 | -9 | -13 | -8 | ||
Asia Pacific($M) | -22 | -18 | -14 | -29 | -18 | -19 | -13 | -23 | -22 | -10 | -9 | ||
Europe($M) | -25 | -18 | -12 | -8 | -30 | -13 | -13 | -8 | |||||
Latin America($M) | -38 | -38 | -39 | -45 | -46 | -21 | -28 | -46 | -34 | -25 | -21 | ||
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)2 | |||||||||||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)5 | |||||||||||||
Global Toothpaste Market Share, Year-to-Date (%)(%)1 | 41.4% | 41.3% | 41.1% | 41.3% | 41.2% | 41.1% | 40.9% | 41.4% | 41.6% | 41.5% | 41.3% | 41.1% | |
Global Toothpaste Market Share YoY Change (share points)(%) | 0.3% | 0.2% | 0.0% | -0.5% | -0.6% | -0.5% | 0.5% | 0.9% | 1.0% | ||||
Global Manual Toothbrush Market Share, Year-to-Date (%)(%)1 | 33.1% | 32.7% | 32.6% | 32.4% | 32.4% | 32.4% | 31.9% | 32.2% | 32.3% | 32.2% | 31.7% | 31.5% | |
Global Manual Toothbrush Market Share YoY Change (share points)(%) | 0.8% | 0.6% | 0.8% | 0.3% | 0.4% | 0.3% | 0.9% | 1.0% | 1.4% | ||||
Worldwide Net Sales Mix by Product Category (%)4 | |||||||||||||
Oral Care (% of Worldwide Net Sales)(%) | 44.0% | 44.0% | 44.0% | 44.0% | 43.0% | 44.0% | 44.0% | 42.0% | 43.0% | ||||
Personal Care (% of Worldwide Net Sales)(%) | 17.0% | 18.0% | 17.0% | 18.0% | 18.0% | 17.0% | 18.0% | 19.0% | 18.0% | ||||
Home Care (% of Worldwide Net Sales)(%) | 16.0% | 16.0% | 17.0% | 16.0% | 16.0% | 16.0% | 16.0% | 17.0% | 17.0% | ||||
Pet Nutrition (% of Worldwide Net Sales)(%) | 23.0% | 22.0% | 22.0% | 22.0% | 23.0% | 23.0% | 22.0% | 22.0% | 22.0% | ||||
Worldwide Net Sales Mix by Operating Division (%)7 | |||||||||||||
North America Share of Worldwide Net Sales (%)(%) | 17.0% | 17.0% | 17.0% | 19.0% | 19.0% | 20.0% | 20.0% | 21.0% | 20.0% | 20.0% | 20.0% | 20.0% | |
Latin America Share of Worldwide Net Sales (%)(%) | 25.0% | 26.0% | 25.0% | 24.0% | 23.0% | 24.0% | 23.0% | 22.4% | 23.0% | 25.0% | 25.0% | 24.0% | |
Europe, Middle East & Africa (EMEA) Share of Worldwide Net Sales (%)(%) | 21.0% | 21.0% | 21.0% | ||||||||||
Asia Pacific Share of Worldwide Net Sales (%)(%) | 15.0% | 14.0% | 15.0% | 14.0% | 14.0% | 13.0% | 14.0% | 14.6% | 14.0% | 14.0% | 14.0% | 14.0% | |
Hill's Pet Nutrition Share of Worldwide Net Sales (%)(%) | 22.0% | 22.0% | 22.0% | 23.0% | 22.0% | 23.0% | 23.0% | 23.1% | 22.0% | 22.0% | 22.0% | 23.0% | |
Europe (Legacy Structure through Q4 2025) Share of Worldwide Net Sales (%)(%) | 14.0% | 16.0% | 14.0% | 14.0% | 13.5% | 15.0% | 14.0% | 14.0% | 14.0% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025) Share of Worldwide Net Sales (%)(%) | 6.0% | 6.0% | 6.0% | 6.0% | 5.4% | 6.0% | 5.0% | 5.0% | 5.0% | ||||
Organic Sales Growth YoY (%)(%)12 | 3.6% | 2.4% | 2.9% | 2.2% | 0.4% | 1.8% | 1.4% | 4.3% | 6.8% | 9.0% | 9.8% | 7.0% | |
Total Oral, Personal and Home Care(%) | 3.1% | 2.4% | 3.1% | 2.5% | 0.9% | 1.7% | 1.0% | 4.7% | 6.8% | 9.8% | 11.4% | 7.5% | |
North America(%) | -1.6% | -3.0% | -2.2% | -1.8% | -0.5% | -0.9% | -3.0% | -0.7% | -1.9% | 2.5% | 4.0% | 3.5% | |
Latin America(%) | 6.0% | 5.3% | 5.4% | 6.5% | 1.7% | 3.4% | 4.0% | 9.2% | 14.2% | 18.8% | 25.9% | 16.5% | |
Europe, Middle East & Africa (EMEA)(%) | 2.7% | 2.0% | 3.5% | ||||||||||
Asia Pacific(%) | 4.6% | 5.2% | 5.6% | 0.1% | -1.0% | 0.0% | -3.1% | 3.8% | 6.1% | 5.1% | 1.5% | 1.0% | |
Hill's Pet Nutrition(%) | 5.7% | 2.1% | 2.1% | 1.5% | -1.3% | 2.0% | 2.9% | 2.9% | 6.5% | 6.1% | 4.2% | 4.5% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 5.4% | 4.8% | 6.2% | 4.5% | 1.0% | 2.8% | 1.7% | 7.5% | 11.1% | 14.6% | 15.7% | 10.5% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | 2.3% | 0.5% | 0.2% | 0.5% | -0.1% | 0.9% | 1.1% | 1.7% | 3.2% | 4.5% | 4.9% | 4.0% | |
Europe (Legacy Structure through Q4 2025)(%) | 1.8% | 1.2% | 2.0% | 5.4% | 4.5% | 6.3% | 6.5% | 7.2% | 3.5% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 10.3% | 6.2% | 7.7% | 1.8% | 9.4% | 10.8% | 16.4% | 16.2% | 17.0% | ||||
Private-Label Pet Food Exit Impact on Consolidated Organic Sales Growth (%)(%) | -0.2% | -0.4% | -0.6% | -0.9% | -0.8% | -0.6% | -0.4% | -0.5% | |||||
Private-Label Pet Food Exit Impact on Hill's Pet Nutrition Organic Sales Growth (bps)(bps) | -70 | -200 | -260 | -370 | -310 | -210 | |||||||
Organic Volume Change YoY (%)(%)10 | 1.7% | 0.8% | 0.6% | -0.5% | -1.9% | -0.2% | -0.1% | 2.5% | 3.7% | 4.7% | 1.3% | 0.0% | |
Total Oral, Personal and Home Care(%) | 1.6% | 1.5% | 1.3% | -0.1% | -1.3% | 0.0% | 0.0% | 2.9% | 3.7% | 5.4% | 2.8% | 1.0% | |
North America(%) | -3.7% | -3.9% | -3.2% | -2.3% | -0.5% | -0.4% | -2.3% | 1.9% | 1.2% | 5.9% | 2.9% | 0.5% | |
Latin America(%) | 3.9% | 2.6% | 2.0% | 2.3% | -1.9% | 0.4% | 2.7% | 0.9% | 3.3% | 5.5% | 6.2% | 8.0% | |
Europe, Middle East & Africa (EMEA)(%) | 3.5% | 3.2% | 2.2% | ||||||||||
Asia Pacific(%) | 1.9% | 4.1% | 4.6% | -2.2% | -3.5% | -1.6% | -3.4% | 5.8% | 6.5% | 3.4% | -2.9% | -4.5% | |
Hill's Pet Nutrition(%) | 1.8% | -1.8% | -1.7% | -1.5% | -4.2% | -0.9% | -0.3% | 0.8% | 3.6% | 2.5% | -3.9% | -4.0% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 3.7% | 2.8% | 3.5% | 0.3% | -2.6% | 0.2% | 0.2% | 3.7% | 4.6% | 5.6% | 2.2% | 2.5% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | 0.1% | -0.9% | -1.7% | -1.0% | -1.4% | -0.5% | -0.4% | 1.5% | 3.0% | 4.0% | 0.6% | -2.0% | |
Europe (Legacy Structure through Q4 2025)(%) | 0.8% | 0.8% | -0.2% | 3.0% | 1.7% | 4.1% | 5.2% | 3.1% | -4.0% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 1.1% | -1.1% | 4.3% | -2.3% | 11.5% | 6.9% | 8.4% | 3.9% | 7.5% | ||||
As-Reported Volume Change YoY (Including Acquisitions & Divestments, %)(%)10 | 1.7% | 0.9% | 1.1% | 0.0% | -1.5% | 0.0% | -0.1% | 2.5% | 3.7% | 4.7% | 1.3% | 0.0% | |
Total Oral, Personal and Home Care(%) | 1.6% | 1.5% | 1.3% | -0.1% | -1.3% | 0.0% | 0.0% | 2.9% | 3.7% | 5.4% | 2.8% | 1.0% | |
North America(%) | -3.7% | -3.9% | -3.2% | -2.3% | -0.5% | -0.4% | -2.3% | 1.9% | 1.2% | 5.9% | 2.9% | 0.5% | |
Latin America(%) | 3.9% | 2.6% | 2.0% | 2.3% | -1.9% | 0.4% | 2.7% | 0.9% | 3.3% | 5.5% | 6.2% | 8.0% | |
Europe, Middle East & Africa (EMEA)(%) | 3.5% | 3.2% | 2.2% | ||||||||||
Asia Pacific(%) | 1.9% | 4.1% | 4.6% | -2.2% | -3.5% | -1.6% | -3.4% | 5.8% | 6.5% | 3.4% | -2.9% | -4.5% | |
Hill's Pet Nutrition(%) | 1.8% | -1.2% | 0.2% | 0.3% | -2.6% | 0.1% | -0.3% | 0.8% | 3.6% | 2.5% | -3.9% | -4.0% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 3.7% | 2.8% | 3.5% | 0.3% | -2.6% | 0.2% | 0.2% | 3.7% | 4.6% | 5.6% | 2.2% | 2.5% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | 0.1% | -0.6% | -0.9% | -0.3% | -0.7% | -0.1% | -0.4% | 1.5% | 3.0% | 4.0% | 0.6% | -2.0% | |
Europe (Legacy Structure through Q4 2025)(%) | 0.8% | 0.8% | -0.2% | 3.0% | 1.7% | 4.1% | 5.2% | 3.1% | -4.0% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 1.1% | -1.1% | 4.3% | -2.3% | 11.5% | 6.9% | 8.4% | 3.9% | 7.5% | ||||
Net Selling Price Change YoY (Pricing, Coupons & Trade Incentives, %)(%)10 | 2.0% | 1.6% | 2.2% | 2.7% | 2.3% | 2.0% | 1.5% | 1.8% | 3.1% | 4.2% | 8.5% | 7.0% | |
Total Oral, Personal and Home Care(%) | 1.4% | 0.9% | 1.8% | 2.6% | 2.1% | 1.7% | 1.0% | 1.8% | 3.1% | 4.4% | 8.6% | 6.5% | |
North America(%) | 2.2% | 0.9% | 1.0% | 0.5% | 0.1% | -0.5% | -0.7% | -2.7% | -3.2% | -3.3% | 1.2% | 3.0% | |
Latin America(%) | 2.1% | 2.8% | 3.4% | 4.2% | 3.6% | 3.0% | 1.2% | 8.3% | 10.9% | 13.3% | 19.7% | 8.5% | |
Europe, Middle East & Africa (EMEA)(%) | -0.9% | -1.2% | 1.2% | ||||||||||
Asia Pacific(%) | 2.8% | 1.1% | 1.0% | 2.3% | 2.5% | 1.6% | 0.4% | -2.0% | -0.3% | 1.7% | 4.4% | 5.5% | |
Hill's Pet Nutrition(%) | 3.9% | 3.9% | 3.8% | 3.0% | 2.9% | 2.9% | 3.2% | 2.0% | 2.8% | 3.7% | 8.2% | 8.5% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 1.7% | 1.9% | 2.7% | 4.2% | 3.6% | 2.6% | 1.4% | 3.8% | 6.5% | 9.0% | 13.5% | 8.0% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | 2.2% | 1.3% | 1.9% | 1.5% | 1.3% | 1.4% | 1.5% | 0.3% | 0.2% | 0.4% | 4.3% | 6.0% | |
Europe (Legacy Structure through Q4 2025)(%) | 1.0% | 0.4% | 2.2% | 2.4% | 2.7% | 2.2% | 1.3% | 4.1% | 7.5% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 9.1% | 7.3% | 3.4% | 4.1% | -2.1% | 3.9% | 8.0% | 12.2% | 9.5% | ||||
Foreign Exchange Impact on Net Sales YoY (%)(%)10 | 1.0% | 2.4% | 5.1% | 3.1% | 1.2% | -1.0% | -4.4% | -4.4% | -4.4% | -4.1% | -3.6% | 0.0% | |
Total Oral, Personal and Home Care(%) | 1.3% | 2.9% | 5.9% | 3.6% | 1.3% | -1.5% | -5.3% | -5.5% | -5.5% | -5.0% | -4.5% | 0.0% | |
North America(%) | -0.2% | 0.0% | 0.4% | 0.3% | 0.1% | -0.1% | -0.6% | -0.3% | -0.2% | -0.1% | 0.0% | 0.0% | |
Latin America(%) | 6.5% | 8.4% | 9.5% | 6.3% | 0.3% | -8.2% | -12.7% | -16.4% | -17.4% | -11.2% | -9.4% | 1.5% | |
Europe, Middle East & Africa (EMEA)(%) | -1.2% | 1.6% | 8.5% | ||||||||||
Asia Pacific(%) | -1.1% | -0.3% | 3.3% | -0.4% | -0.5% | 0.9% | -1.9% | 0.0% | 0.2% | -2.5% | -3.0% | -0.5% | |
Hill's Pet Nutrition(%) | -0.1% | 0.6% | 2.7% | 1.6% | 1.1% | 0.8% | -1.4% | -0.5% | -0.1% | -0.7% | -0.3% | 0.5% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 2.7% | 4.4% | 6.7% | 4.3% | 0.6% | -3.9% | -7.9% | -9.7% | -10.1% | -8.6% | -8.1% | -1.5% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | -0.3% | 0.9% | 3.9% | 2.2% | 1.7% | 1.4% | -1.5% | -0.2% | 0.4% | -0.4% | 0.2% | 1.5% | |
Europe (Legacy Structure through Q4 2025)(%) | 8.1% | 6.4% | 5.7% | -2.9% | 0.4% | 1.6% | -0.2% | 2.3% | 6.5% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 4.7% | 0.6% | 0.2% | -3.4% | -6.6% | -6.0% | -14.3% | -20.7% | -21.0% | ||||
As-Reported Net Sales Growth YoY (%)(%)10 | 4.6% | 4.9% | 8.4% | 5.8% | 2.0% | 1.0% | -3.1% | -0.1% | 2.4% | 4.9% | 6.2% | 7.0% | |
Total Oral, Personal and Home Care(%) | 4.4% | 5.4% | 8.9% | 6.0% | 2.1% | 0.2% | -4.3% | -0.8% | 1.3% | 4.7% | 6.8% | 7.5% | |
North America(%) | -1.7% | -3.0% | -1.8% | -1.5% | -0.4% | -1.0% | -3.6% | -1.0% | -2.1% | 2.5% | 4.0% | 3.5% | |
Latin America(%) | 12.5% | 13.7% | 14.8% | 12.8% | 2.0% | -4.8% | -8.7% | -7.2% | -3.2% | 7.6% | 16.5% | 18.0% | |
Europe, Middle East & Africa (EMEA)(%) | 1.4% | 3.5% | 11.9% | ||||||||||
Asia Pacific(%) | 3.5% | 4.9% | 8.9% | -0.3% | -1.5% | 0.8% | -5.0% | 3.7% | 6.3% | 2.6% | -1.5% | 0.5% | |
Hill's Pet Nutrition(%) | 5.6% | 3.4% | 6.7% | 4.9% | 1.4% | 3.8% | 1.5% | 2.3% | 6.3% | 5.5% | 3.9% | 5.0% | |
Emerging Markets (Latin America, Asia ex-Japan, Africa/Eurasia & Eastern Europe)(%) | 8.0% | 9.2% | 12.9% | 8.7% | 1.6% | -1.1% | -6.2% | -2.2% | 1.0% | 5.9% | 7.5% | 9.0% | |
Developed Markets (North America, Western Europe, Japan & Australia)(%) | 2.0% | 1.6% | 4.9% | 3.5% | 2.3% | 2.8% | -0.4% | 1.6% | 3.6% | 4.0% | 5.1% | 5.5% | |
Europe (Legacy Structure through Q4 2025)(%) | 9.8% | 7.6% | 7.8% | 2.5% | 4.9% | 8.0% | 6.2% | 9.5% | 10.0% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 15.0% | 6.8% | 8.0% | -1.5% | 2.8% | 4.8% | 2.2% | -4.5% | -4.0% | ||||
Segment Operating Profit Growth YoY (%)7 | |||||||||||||
North America(%) | -11.0% | 3.0% | -28.0% | -1.0% | -8.0% | -9.0% | -8.0% | -11.0% | -9.0% | -2.0% | 15.0% | 19.0% | |
Latin America(%) | 17.0% | 14.0% | 15.0% | 6.0% | -8.0% | -12.0% | -14.0% | -8.0% | -2.0% | 15.0% | 29.0% | 26.0% | |
Europe, Middle East & Africa (EMEA)(%) | 8.0% | 9.0% | 20.0% | ||||||||||
Asia Pacific(%) | -1.0% | 3.0% | 9.0% | -11.0% | -6.0% | -4.0% | -4.0% | 4.0% | 3.0% | 16.0% | 2.0% | 12.0% | |
Hill's Pet Nutrition(%) | 5.0% | 2.0% | 8.0% | 4.0% | -1.0% | 13.0% | 30.0% | 19.0% | 28.0% | 23.0% | 9.0% | -1.0% | |
Europe (Legacy Structure through Q4 2025)(%) | 17.0% | 16.0% | 9.0% | 12.0% | 3.0% | 10.0% | 19.0% | 24.0% | 35.0% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025)(%) | 13.0% | 5.0% | 1.0% | -14.0% | -1.0% | -1.0% | 4.0% | -3.0% | -15.0% | ||||
Net Sales by Reportable Operating Segment ($M)($M) | 5,369 | 5,361 | 5,324 | 5,230 | 5,131 | 5,110 | 4,911 | 4,944 | 5,033 | 5,058 | 5,065 | 4,950 | |
Cost of Sales by Reportable Operating Segment (ASC 280 Significant Expense, $M)7 | |||||||||||||
North America Cost of Sales ($M)($M) | 381 | 340 | 390 | 391 | 381 | 380 | 358 | 310 | 381 | 396 | 390 | ||
Latin America Cost of Sales ($M)($M) | 570 | 583 | 554 | 552 | 541 | 527 | 487 | 469 | 459 | 504 | 502 | ||
Europe, Middle East & Africa (EMEA) Cost of Sales ($M)($M) | 418 | 405 | 408 | 393 | 417 | 395 | 367 | ||||||
Asia Pacific Cost of Sales ($M)($M) | 300 | 291 | 295 | 290 | 288 | 284 | 275 | 330 | 269 | 260 | 284 | ||
Hill's Pet Nutrition Cost of Sales ($M)($M) | 461 | 448 | 455 | 462 | 457 | 462 | 437 | 465 | 463 | 459 | 482 | ||
Europe (Legacy Structure through Q4 2025) Cost of Sales ($M)($M) | 218 | 300 | 275 | 258 | 268 | 275 | 258 | 267 | |||||
Africa/Eurasia (Legacy Structure through Q4 2025) Cost of Sales ($M)($M) | 93 | 118 | 117 | 104 | 123 | 109 | 105 | 106 | |||||
Selling, General & Administrative Expenses by Segment (ASC 280 Significant Expense, $M)7 | |||||||||||||
North America SG&A Expenses ($M)($M) | 351 | 362 | 359 | 333 | 342 | 349 | 350 | 139 | 409 | 426 | 419 | ||
Latin America SG&A Expenses ($M)($M) | 361 | 377 | 357 | 332 | 303 | 318 | 316 | 305 | 325 | 353 | 345 | ||
Europe, Middle East & Africa (EMEA) SG&A Expenses ($M)($M) | 436 | 438 | 438 | 425 | 435 | 428 | 399 | ||||||
Asia Pacific SG&A Expenses ($M)($M) | 296 | 292 | 289 | 292 | 280 | 265 | 264 | 322 | 264 | 232 | 242 | ||
Hill's Pet Nutrition SG&A Expenses ($M)($M) | 475 | 476 | 456 | 437 | 427 | 430 | 422 | 402 | 406 | 420 | 413 | ||
Europe (Legacy Structure through Q4 2025) SG&A Expenses ($M)($M) | 220 | 285 | 272 | 254 | 122 | 280 | 251 | 245 | |||||
Africa/Eurasia (Legacy Structure through Q4 2025) SG&A Expenses ($M)($M) | 72 | 106 | 110 | 106 | 76 | 99 | 103 | 99 | |||||
Other (Income) Expense, Net by Operating Segment (ASC 280, $M)7 | |||||||||||||
North America Other (Income) Expense, Net ($M)($M) | -3 | -3 | -2 | 2 | -1 | 3 | 0 | -32 | 8 | 3 | 13 | ||
Latin America Other (Income) Expense, Net ($M)($M) | 2 | -6 | 1 | 4 | -2 | -6 | -7 | -7 | 7 | -6 | 1 | ||
Europe, Middle East & Africa (EMEA) Other (Income) Expense, Net ($M)($M) | 14 | 15 | 14 | 22 | 20 | 19 | 18 | ||||||
Asia Pacific Other (Income) Expense, Net ($M)($M) | -6 | -10 | -2 | -3 | -6 | -6 | -5 | -2 | -8 | -6 | -7 | ||
Hill's Pet Nutrition Other (Income) Expense, Net ($M)($M) | 2 | 2 | 3 | 10 | 2 | 0 | 1 | -1 | -1 | 1 | 9 | ||
Europe (Legacy Structure through Q4 2025) Other (Income) Expense, Net ($M)($M) | 11 | 7 | 7 | 7 | 9 | 8 | 7 | 8 | |||||
Africa/Eurasia (Legacy Structure through Q4 2025) Other (Income) Expense, Net ($M)($M) | 4 | 4 | 3 | 4 | -3 | 5 | 1 | 5 | |||||
Operating Profit by Reportable Operating Segment ($M)($M)2 | 1,088 | 1,016 | 964 | 92 | 1,059 | 1,080 | 1,076 | 1,064 | 1,065 | 1,092 | 1,047 | 1,072 | |
North America Operating Profit ($M)($M) | 177 | 192 | 141 | 203 | 199 | 187 | 197 | 206 | 206 | 213 | 214 | 231 | |
Corporate & Unallocated Operating Expense ($M)($M) | -221 | -335 | -346 | -1,194 | -189 | -181 | -153 | -179 | -208 | -201 | -196 | -169 | |
Operating Profit Margin by Operating Segment (% of Segment Net Sales)(%)7 | 20.3% | 19.0% | 18.1% | 1.8% | 20.6% | 21.1% | 21.9% | 21.5% | 21.2% | 21.6% | 20.7% | 21.7% | |
North America Operating Margin (%)(%) | 19.5% | 21.6% | 15.8% | 19.9% | 19.0% | 18.9% | 19.6% | 19.9% | 20.5% | 22.3% | 22.3% | 24.2% | |
Latin America Operating Margin (%)(%) | 29.6% | 30.4% | 30.6% | 28.8% | 28.6% | 30.4% | 30.4% | 30.6% | 31.6% | 32.9% | 32.3% | 30.7% | |
Europe, Middle East & Africa (EMEA) Operating Margin (%)(%) | 23.2% | 23.4% | 23.6% | 21.8% | 22.2% | 22.0% | |||||||
Asia Pacific Operating Margin (%)(%) | 26.4% | 26.7% | 27.6% | 26.0% | 26.2% | 27.2% | 28.7% | 29.1% | 27.4% | 28.7% | 28.5% | 29.0% | |
Hill's Pet Nutrition Operating Margin (%)(%) | 22.2% | 22.5% | 23.4% | 23.9% | 22.4% | 22.9% | 23.1% | 24.1% | 22.9% | 21.1% | 18.0% | 20.7% | |
Europe (Legacy Structure through Q4 2025) Operating Margin (%)(%) | 24.9% | 26.1% | 25.0% | 24.9% | 23.3% | 24.3% | 22.1% | 20.3% | 20.5% | ||||
Africa/Eurasia (Legacy Structure through Q4 2025) Operating Margin (%)(%) | 21.1% | 23.0% | 22.0% | 21.0% | 21.5% | 23.4% | 23.4% | 23.9% | 22.3% | ||||
Operating Profit Margin YoY Change by Operating Segment (bps)(bps)7 | -30 | -210 | -380 | -60 | -50 | 120 | -20 | 30 | 140 | 160 | 1,730 | ||
North America Operating Margin Change YoY (bps)(bps) | -210 | 120 | -590 | 0 | -150 | -170 | -100 | -220 | -170 | -90 | 220 | 310 | |
Latin America Operating Margin Change YoY (bps)(bps) | 100 | 0 | 20 | -180 | -300 | -250 | -190 | -10 | 40 | 210 | 300 | 200 | |
Europe, Middle East & Africa (EMEA) Operating Margin Change YoY (bps)(bps) | 140 | 120 | 160 | ||||||||||
Asia Pacific Operating Margin Change YoY (bps)(bps) | -110 | -40 | -10 | -310 | -120 | -150 | 20 | 10 | -90 | 320 | 110 | 300 | |
Hill's Pet Nutrition Operating Margin Change YoY (bps)(bps) | -20 | -40 | 30 | -20 | -50 | 180 | 510 | 340 | 390 | 300 | 80 | -130 | |
Europe (Legacy Structure through Q4 2025) Operating Margin Change YoY (bps)(bps) | 160 | 180 | 40 | 220 | -40 | 30 | 230 | 250 | 380 | ||||
Africa/Eurasia (Legacy Structure through Q4 2025) Operating Margin Change YoY (bps)(bps) | -40 | -40 | -140 | -290 | -80 | -140 | 30 | 30 | -300 | ||||
Segment Gross Profit Margin YoY Change (bps, MD&A)4 | |||||||||||||
North America(bps) | -70 | 320 | -440 | -190 | -110 | 90 | 260 | ||||||
Latin America(bps) | 290 | 120 | 40 | -620 | -400 | -260 | 240 | 350 | 420 | ||||
Asia Pacific(bps) | -40 | 100 | 50 | -60 | 130 | 270 | 370 | 160 | |||||
Europe (Legacy Structure)(bps) | -40 | 50 | 240 | 400 | 410 | 340 | |||||||
Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A)4 | |||||||||||||
North America(bps) | 350 | 320 | 210 | 240 | 170 | 190 | 190 | ||||||
Latin America(bps) | 250 | 260 | 270 | 320 | 270 | 250 | 280 | 260 | 230 | ||||
Asia Pacific(bps) | 380 | 270 | 240 | 330 | 260 | 240 | 310 | 210 | |||||
Europe (Legacy Structure)(bps) | 250 | 240 | 180 | 280 | 250 | 270 | |||||||
Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A)3 | |||||||||||||
Latin America(bps) | -80 | -260 | -370 | -780 | -570 | -460 | -380 | -480 | |||||
Asia Pacific(bps) | -550 | -220 | -190 | -190 | -190 | ||||||||
Europe (Legacy Structure)(bps) | -340 | -330 | -60 | 120 | -200 | ||||||||
Segment SG&A Expense Ratio YoY Change (bps, MD&A)2 | |||||||||||||
Latin America(bps) | 160 | 120 | -40 | -250 | -150 | 110 | 170 | ||||||
Asia Pacific(bps) | 70 | 180 | 10 | 110 | 130 | 80 | |||||||
Segment Advertising Investment Ratio YoY Change (bps, MD&A)1 | |||||||||||||
Asia Pacific(bps) | 130 | 120 | 210 | 70 | 310 | 80 | |||||||
Segment Overhead Expense Ratio YoY Change (bps, MD&A)1 | |||||||||||||
Asia Pacific(bps) | -60 | 60 | -190 | 90 | 40 | 110 | 70 | ||||||
Capital Expenditures by Reportable Operating Segment ($M)($M)9 | 134 | 128 | 138 | 177 | 155 | 108 | 124 | 184 | 134 | 117 | 126 | ||
Total Oral, Personal and Home Care Capital Expenditures ($M)($M) | 85 | 90 | 77 | 122 | 103 | 68 | 68 | 127 | 81 | 62 | 47 | ||
North America Capital Expenditures ($M)($M) | 13 | 18 | 14 | 17 | 17 | 13 | 16 | 17 | 9 | 13 | 8 | ||
Latin America Capital Expenditures ($M)($M) | 38 | 38 | 39 | 45 | 46 | 21 | 28 | 46 | 34 | 25 | 21 | ||
Europe, Middle East & Africa (EMEA) Capital Expenditures ($M)($M) | 12 | 16 | 10 | 29 | 22 | 15 | 11 | ||||||
Asia Pacific Capital Expenditures ($M)($M) | 22 | 18 | 14 | 31 | 18 | 19 | 13 | 23 | 22 | 10 | 9 | ||
Hill's Pet Nutrition Capital Expenditures ($M)($M) | 23 | 15 | 22 | 24 | 21 | 22 | 21 | 35 | 24 | 31 | 53 | ||
Corporate Capital Expenditures ($M)($M) | 26 | 23 | 39 | 31 | 31 | 18 | 35 | 22 | 29 | 24 | 26 | ||
Europe (Legacy Structure through FY2025) Capital Expenditures ($M)($M) | 6 | 18 | 12 | 8 | -2 | 13 | 13 | 8 | |||||
Africa/Eurasia (Legacy Structure through FY2025) Capital Expenditures ($M)($M) | 2 | 4 | 2 | 2 | 24 | 3 | 1 | 1 | |||||
Depreciation & Amortization by Reportable Operating Segment ($M)($M)9 | 159 | 155 | 156 | 173 | 158 | 151 | 148 | 148 | 150 | 157 | 150 | ||
Total Oral, Personal and Home Care Depreciation & Amortization ($M)($M) | 100 | 97 | 96 | 101 | 97 | 95 | 92 | 93 | 93 | 96 | 96 | ||
North America Depreciation & Amortization ($M)($M) | 20 | 20 | 19 | 19 | 20 | 19 | 19 | -15 | 30 | 32 | 31 | ||
Latin America Depreciation & Amortization ($M)($M) | 31 | 30 | 29 | 28 | 27 | 27 | 24 | 23 | 24 | 26 | 27 | ||
Europe, Middle East & Africa (EMEA) Depreciation & Amortization ($M)($M) | 27 | 26 | 27 | 33 | 30 | 30 | 29 | ||||||
Asia Pacific Depreciation & Amortization ($M)($M) | 22 | 21 | 21 | 21 | 20 | 19 | 20 | 21 | 20 | 20 | 20 | ||
Hill's Pet Nutrition Depreciation & Amortization ($M)($M) | 34 | 32 | 35 | 46 | 35 | 31 | 31 | 32 | 33 | 37 | 30 | ||
Corporate Depreciation & Amortization ($M)($M) | 25 | 26 | 25 | 26 | 26 | 25 | 25 | 23 | 24 | 24 | 24 | ||
Europe (Legacy Structure through FY2025) Depreciation & Amortization ($M)($M) | 18 | 16 | 16 | 15 | 16 | 17 | 16 | 16 | |||||
Africa/Eurasia (Legacy Structure through FY2025) Depreciation & Amortization ($M)($M) | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Consolidated GAAP Gross Profit Margin YoY Change (bps)4 | |||||||||||||
Funding-the-Growth Productivity Savings Impact on Gross Margin (bps)(bps) | 290 | 280 | 230 | 290 | 250 | 210 | 270 | 280 | 250 | ||||
Net Selling Price Impact on Gross Margin (bps)(bps) | 80 | 60 | 80 | 90 | 80 | 60 | 110 | 160 | 330 | ||||
Product Mix & Other Impact on Gross Margin (bps)(bps) | 20 | 20 | 20 | 30 | 20 | 50 | 40 | ||||||
Raw & Packaging Material Cost Inflation Impact on Gross Margin (bps)(bps) | -300 | -220 | -350 | -600 | -420 | -240 | -150 | -140 | -270 | ||||
Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps)(bps) | 90 | 130 | 40 | 130 | 80 | 160 | |||||||
Worldwide Advertising Investment ($M)($M)1 | 775 | 777 | 734 | 682 | 674 | 678 | 668 | 648 | 694 | 706 | 672 | 593 | |
Advertising Investment as % of Worldwide Net Sales (%)(%) | 14.4% | 14.5% | 13.8% | 13.1% | 13.3% | 13.6% | 13.8% | 14.0% | 13.3% | ||||
Base Business (Non-GAAP) Gross Profit ($M)($M) | 3,238 | 3,297 | 3,226 | 3,146 | 3,049 | 3,069 | 2,987 | 2,983 | 3,083 | 3,075 | 3,039 | 2,950 | |
Base Business (Non-GAAP) Gross Profit Margin (% of Net Sales)(%)1 | 60.3% | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.3% | 60.8% | 60.0% | 59.6% | |
GAAP Gross Profit Margin (% of Net Sales)(%) | 60.2% | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.1% | 60.6% | 60.0% | 59.6% | |
Base Business (Non-GAAP) SG&A Expenses ($M)($M)3 | 2,102 | 2,122 | 2,071 | 1,980 | 1,971 | 1,963 | 1,883 | 1,894 | 1,976 | 1,937 | 1,915 | 1,803 | |
Base Business SG&A Expenses as % of Net Sales (%)(%) | 39.1% | 39.6% | 38.9% | 37.9% | 38.4% | 38.4% | 38.3% | 38.3% | 38.3% | 37.8% | |||
Base Business SG&A % of Net Sales YoY Change (bps)(bps) | 70 | 120 | 60 | -40 | 50 | 170 | |||||||
GAAP SG&A Expenses as % of Net Sales (%)(%) | 39.3% | 39.7% | 39.0% | 39.6% | 38.4% | 38.4% | 38.6% | 38.3% | 38.3% | 37.8% | |||
Base Business (Non-GAAP) Operating Profit ($M)($M)1 | 1,117 | 1,145 | 1,134 | 1,108 | 1,059 | 1,089 | 1,091 | 1,071 | 1,080 | 1,118 | 1,083 | 1,074 | |
Base Business Other (Income) Expense, Net ($M)($M) | 19 | 30 | 21 | 58 | 19 | 17 | 13 | 18 | 27 | 20 | 41 | 73 | |
Base Business (Non-GAAP) Operating Profit Margin (% of Net Sales)(%)2 | 20.8% | 21.4% | 21.3% | 21.2% | 20.6% | 21.3% | 22.2% | 21.7% | 21.5% | 22.1% | 21.4% | 21.7% | |
Base Business Operating Profit Margin YoY Change (bps)(bps) | 20 | 10 | -90 | -50 | -90 | -80 | 80 | 0 | 50 | 150 | 170 | 140 | |
GAAP Operating Profit Margin (% of Net Sales)(%) | 20.3% | 19.0% | 18.1% | 1.8% | 20.6% | 21.1% | 21.9% | 21.5% | 21.2% | 21.6% | 20.7% | 21.7% | |
Base Business (Non-GAAP) Income Before Income Taxes ($M)($M)4 | 1,049 | 1,079 | 1,068 | 1,038 | 1,016 | 1,018 | 1,001 | 1,001 | 1,036 | 1,003 | 991 | ||
GAAP Non-Service Postretirement Costs ($M)($M) | 24 | 21 | 26 | -61 | 21 | 23 | 72 | 20 | 23 | 22 | 22 | 22 | |
Base Business Income Tax Provision ($M)($M) | 244 | 255 | 248 | 238 | 236 | 239 | 216 | 212 | 247 | 244 | 229 | ||
Base Business Effective Income Tax Rate (%)(%) | 23.3% | 23.6% | 23.2% | 22.9% | 23.2% | 23.4% | 21.6% | 21.2% | 23.8% | 24.3% | 23.1% | ||
GAAP Effective Income Tax Rate (%)(%) | 23.6% | 24.3% | 23.6% | 104.7% | 22.8% | 23.2% | 23.7% | 21.6% | 21.3% | 24.1% | 24.6% | 23.1% | |
Base Business (Non-GAAP) Net Income Attributable to Colgate-Palmolive ($M)($M) | 777 | 797 | 784 | 768 | 750 | 743 | 745 | 750 | 753 | 713 | 720 | ||
Base Business (Non-GAAP) Diluted Earnings Per Share ($)($) | 0.97 | 0.99 | 0.97 | 0.95 | 0.92 | 0.91 | 0.91 | 0.91 | 0.91 | 0.86 | 0.87 | ||
Total Common Shares Repurchased (shares)3 | 3,680,167 | 3,223,398 | 3,386,850 | 5,089,081 | 3,408,121 | 2,560,749 | 3,184,766 | 4,795,250 | 2,870,776 | 4,827,034 | 6,264,873 | 2,884,952 | |
Shares Repurchased Under Publicly Announced Board Programs (shares) | 3,361,109 | 3,195,452 | 3,095,656 | 5,073,677 | 3,052,859 | 2,550,017 | 2,975,767 | 4,775,948 | 2,619,161 | 4,820,777 | 6,105,536 | 2,839,064 | |
Average Price Paid per Repurchased Common Share ($)($) | 89.70 | 87.40 | 90.28 | 78.54 | 84.47 | 90.65 | 89.04 | 94.55 | 103 | 93.27 | 85.93 | 75.89 | |
Remaining Share Repurchase Program Authorization at Period-End ($M)($M) | 3,228 | 3,530 | 3,809 | 4,087 | 4,485 | 4,744 | 4,974 | 1,183 | 1,635 | 1,904 | 2,354 | 2,879 | |
Free Cash Flow Before Dividends ($M)($M) | 1,037 | 867 | 609 | 1,276 | 1,106 | 776 | 476 | 1,085 | 1,033 | 873 | 555 | 939 | |
Net Debt ($M, Earnings Release Definition)($M)2 | 6,104 | 6,404 | 6,554 | 6,593 | 6,947 | 7,346 | 6,958 | 6,693 | 6,942 | 7,341 | 7,379 | 7,404 | |
Marketable Securities ($M)($M) | 85 | 83 | 84 | 107 | 193 | 197 | 199 | 160 | 260 | 225 | 231 | 179 | |
Working Capital as % of Net Sales (%)(%) | -6.3% | -5.9% | -5.7% | -7.0% | -4.0% | -2.9% | -3.3% | -5.2% | -3.6% | -2.5% | -2.2% | -1.4% | |
Commercial Paper Borrowings Outstanding at Period-End ($M)($M)1 | 1,037 | 1,149 | 1,258 | 147 | 1,289 | 1,115 | 1,170 | 936 | 1,282 | 1,607 | 1,599 | 906 | |
Average Daily Commercial Paper Borrowings During Period ($M)($M) | 1,405 | 1,321 | 893 | 1,733 | 1,694 | 1,478 | 1,754 | 1,688 | 1,383 | ||||
Restructuring & Productivity Program Accrual Balance at Period-End ($M)($M)2 | 172 | 228 | 164 | 10 | 34 | 36 | 39 | 44 | 51 | 51 | 41 | 11 | |
Employee-Related Severance & Benefits Restructuring Accrual ($M)($M) | 153 | 210 | 155 | 6 | 28 | 29 | 31 | 34 | 45 | 48 | 39 | 10 | |
Incremental Asset-Related & Other Restructuring Accrual ($M)($M) | 19 | 18 | 9 | 4 | 6 | 7 | 8 | 10 | 6 | 3 | 2 | 1 | |
Colgate India — Product Sales, Net of GST (INR Lakhs)(M)1 | 169,157 | 159,056 | 158,277 | 150,724 | 142,064 | ||||||||
Colgate India — Other Operating Revenue (INR Lakhs)(M) | 1,422 | 1,274 | 1,258 | 1,226 | 1,342 | ||||||||
Colgate India — Total Revenue from Operations (INR Lakhs)1 | |||||||||||||
Colgate India — Total Income Including Interest & Other Income (INR Lakhs)(M)1 | 172,750 | 162,610 | 161,222 | 153,453 | 145,200 | ||||||||
Colgate India — Other Non-Operating Income (INR Lakhs)(M) | 2,171 | 2,280 | 1,687 | 1,503 | 1,794 | ||||||||
Colgate India — Total Operating Expenses (INR Lakhs)(M)5 | 126,728 | 116,057 | 112,161 | 109,225 | 102,005 | ||||||||
Colgate India — Cost of Raw & Packaging Materials Consumed (INR Lakhs)(M) | 42,992 | 43,277 | 42,679 | 39,368 | 34,573 | ||||||||
Colgate India — Purchases of Finished Stock-in-Trade (INR Lakhs)(M) | 8,944 | 8,951 | 7,713 | 8,443 | 4,002 | ||||||||
Colgate India — Employee Benefits Expense (INR Lakhs)(M) | 13,592 | 12,926 | 12,080 | 11,806 | 11,820 | ||||||||
Colgate India — Advertising & Brand Promotion Spend (INR Lakhs)(M) | 31,482 | 25,186 | 19,905 | 22,510 | 18,841 | ||||||||
Colgate India — Depreciation & Amortization Expense (INR Lakhs)(M) | 3,416 | 3,921 | 3,508 | 3,719 | 3,754 | ||||||||
Colgate India — Net Profit After Tax (INR Lakhs)(M)2 | 34,157 | 34,308 | 35,332 | 32,751 | 32,062 | ||||||||
Colgate India — Profit Before Exceptional Items and Tax (INR Lakhs)(M) | 46,022 | 46,553 | 49,061 | 44,228 | 43,195 | ||||||||
Colgate India — Profit Before Tax (INR Lakhs)(M) | 46,022 | 46,219 | 47,403 | 44,228 | 43,195 | ||||||||
Consolidated Net Sales ($M)($M)3 | 5,369 | 5,361 | 5,324 | 5,230 | 5,131 | 5,110 | 4,911 | 4,945 | 5,033 | 5,058 | 5,065 | 4,950 | |
Cost of Sales ($M)($M) | 2,136 | 2,065 | 2,098 | 2,084 | 2,082 | 2,041 | 1,924 | 1,963 | 1,959 | 1,992 | 2,026 | 2,000 | |
Gross Profit ($M)($M) | 3,233 | 3,296 | 3,226 | 3,146 | 3,049 | 3,069 | 2,987 | 2,982 | 3,074 | 3,066 | 3,039 | 2,950 | |
Selling, General and Administrative Expenses ($M)($M) | 2,111 | 2,130 | 2,076 | 2,070 | 1,971 | 1,963 | 1,898 | 1,896 | 1,979 | 1,939 | 1,916 | 1,803 | |
Consolidated Operating Profit ($M)($M)6 | 1,088 | 1,016 | 964 | 92 | 1,059 | 1,080 | 1,076 | 1,063 | 1,065 | 1,092 | 1,047 | 1,072 | |
Interest Expense ($M)($M) | 62 | 62 | 62 | 64 | 67 | 71 | 66 | 66 | 74 | 78 | 73 | ||
Interest Income ($M)($M) | 17 | 17 | 16 | 19 | 21 | 21 | 15 | 16 | 18 | 18 | 15 | ||
Income Before Income Taxes ($M)($M) | 1,019 | 950 | 892 | 108 | 992 | 1,007 | 953 | 993 | 986 | 1,010 | 967 | 988 | |
Provision for Income Taxes ($M)($M) | 240 | 231 | 211 | 113 | 226 | 234 | 227 | 214 | 210 | 243 | 238 | 228 | |
Net Income Attributable to Noncontrolling Interests ($M)($M) | 28 | 26 | 35 | 32 | 31 | 30 | 36 | 40 | 39 | 36 | 46 | 42 | |
Net Income Attributable to Colgate-Palmolive Company ($M)($M) | 751 | 693 | 646 | -37 | 735 | 743 | 690 | 739 | 737 | 731 | 683 | 718 | |
Diluted Earnings Per Common Share ($)($)4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Basic Earnings Per Common Share ($)($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Dividends Declared Per Common Share ($)($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Weighted-Average Diluted Common Shares Outstanding (millions)(M) | 800 | 802 | 805 | 810 | 813 | 815 | 823 | 824 | 826 | ||||
Weighted-Average Basic Common Shares Outstanding (millions)(M) | 797 | 799 | 802 | 808 | 810 | 812 | 818 | 820 | 823 | ||||
Consolidated Total Assets ($M)($M)7 | 16,742 | 16,790 | 16,610 | 16,330 | 17,513 | 17,470 | 16,647 | 16,046 | 16,774 | 16,480 | 16,571 | 16,393 | |
Cash and Cash Equivalents ($M)($M) | 1,527 | 1,370 | 1,335 | 1,288 | 1,279 | 1,215 | 1,112 | 1,096 | 1,234 | 1,110 | 1,079 | 966 | |
Receivables, Net ($M)($M) | 1,901 | 1,962 | 1,889 | 1,675 | 1,807 | 1,773 | 1,725 | 1,521 | 1,712 | 1,825 | 1,813 | 1,586 | |
Inventories ($M)($M) | 2,182 | 2,181 | 2,086 | 2,032 | 2,109 | 2,120 | 2,125 | 1,987 | 2,041 | 1,922 | 1,914 | 1,934 | |
Total Current Assets ($M)($M) | 6,357 | 6,308 | 6,082 | 5,709 | 6,039 | 5,996 | 5,814 | 5,317 | 5,806 | 5,646 | 5,640 | 5,279 | |
Property, Plant and Equipment, Net ($M)($M)2 | 4,613 | 4,639 | 4,622 | 4,660 | 4,560 | 4,529 | 4,416 | 4,422 | 4,421 | 4,392 | 4,497 | 4,582 | |
Property, Plant and Equipment, Gross ($M)($M) | 11,097 | 11,020 | 10,887 | 10,856 | 10,847 | 10,665 | 10,276 | 10,127 | 10,238 | 10,167 | 10,261 | 10,286 | |
Accumulated Depreciation ($M)($M) | -6,484 | -6,381 | -6,265 | -6,196 | -6,287 | -6,136 | -5,860 | -5,705 | -5,817 | -5,775 | -5,764 | -5,704 | |
Goodwill ($M)($M) | 3,080 | 3,100 | 3,107 | 3,122 | 3,702 | 3,696 | 3,334 | 3,272 | 3,389 | 3,320 | 3,341 | 3,410 | |
Other Intangible Assets, Net ($M)($M) | 1,472 | 1,495 | 1,521 | 1,536 | 1,889 | 1,904 | 1,782 | 1,756 | 1,834 | 1,814 | 1,837 | 1,887 | |
Consolidated Total Liabilities and Shareholders' Equity ($M)($M)9 | 16,742 | 16,790 | 16,610 | 16,330 | 17,513 | 17,470 | 16,647 | 16,046 | 16,774 | 16,480 | 16,571 | 16,393 | |
Accounts Payable ($M)($M) | 2,096 | 2,115 | 2,096 | 2,089 | 1,866 | 1,790 | 1,800 | 1,805 | 1,625 | 1,557 | 1,646 | 1,698 | |
Total Current Liabilities ($M)($M) | 6,639 | 6,148 | 5,934 | 6,853 | 6,496 | 6,775 | 6,861 | 5,759 | 5,565 | 5,350 | 5,314 | 4,741 | |
Long-Term Debt ($M)($M) | 7,184 | 7,823 | 7,937 | 6,871 | 7,306 | 7,144 | 6,571 | 7,289 | 7,909 | 8,146 | 8,151 | 8,219 | |
Total Liabilities ($M)($M) | 16,102 | 16,224 | 16,124 | 15,965 | 16,275 | 16,418 | 15,914 | 15,502 | 15,938 | 15,998 | 15,954 | 15,436 | |
Retained Earnings ($M)($M) | 27,415 | 27,085 | 26,816 | 26,595 | 27,051 | 26,735 | 26,413 | 26,145 | 25,814 | 25,486 | 25,164 | 25,289 | |
Common Stock in Treasury ($M)($M) | -29,201 | -28,931 | -28,656 | -28,450 | -28,057 | -27,821 | -27,602 | -27,358 | -26,913 | -26,736 | -26,343 | -26,017 | |
Total Colgate-Palmolive Company Shareholders' Equity ($M)($M) | 288 | 236 | 145 | 54 | 856 | 702 | 363 | 212 | 435 | 123 | 230 | 609 | |
Noncontrolling Interests ($M)($M) | 352 | 330 | 341 | 311 | 382 | 350 | 370 | 332 | 401 | 359 | 387 | 348 | |
Total Equity ($M)($M) | 640 | 566 | 486 | 365 | 1,238 | 1,052 | 733 | 544 | 836 | 482 | 617 | 957 | |
Net Cash Provided by Operations ($M)($M)8 | 1,171 | 995 | 747 | 1,453 | 1,261 | 884 | 600 | 1,269 | 1,167 | 990 | 681 | 1,136 | |
Capital Expenditures ($M)($M) | 134 | 128 | 138 | 177 | 155 | 108 | 124 | 184 | 134 | 117 | 126 | 197 | |
Depreciation and Amortization ($M)($M) | 159 | 155 | 156 | 173 | 158 | 151 | 148 | 148 | 150 | 157 | 150 | 150 | |
Stock-Based Compensation Expense ($M)($M) | 63 | 38 | 40 | 28 | 72 | 32 | 23 | 27 | 65 | 24 | 19 | 25 | |
Net Cash Used in Investing Activities ($M)($M) | -137 | -122 | -122 | -103 | -154 | -401 | -159 | -80 | -150 | -111 | -193 | -143 | |
Principal Payments on Share Repurchases ($M)($M) | 330 | 291 | 306 | 406 | 288 | 232 | 284 | 455 | 295 | 480 | 509 | 245 | |
Net Cash Used in Financing Activities ($M)($M) | -858 | -851 | -563 | -1,361 | -1,028 | -409 | -458 | -1,279 | -904 | -845 | -361 | -992 | |
Income Taxes Paid ($M)($M) | 189 | 283 | 176 | 201 | 182 | 391 | 139 | 171 | 257 | 355 | 150 | 211 | |
Interest Paid ($M)($M) | 78 | 31 | 96 | 35 | 98 | 28 | 109 | 35 | 106 | 38 | 123 | 37 | |
8 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Primary operational metrics: global year-to-date market shares in toothpaste and manual toothbrushes, product category revenue mix (Oral Care, Personal Care, Home Care, Pet Nutrition), and the complete decomposition of top-line sales growth into organic volume, as-reported volume, net selling price, and foreign exchange across all operating divisions and Emerging vs. Developed markets.
- Segment realignment (Q1 2026): effective January 1, 2026, Colgate-Palmolive combined its Europe and Africa/Eurasia operating segments (along with skin health) into Europe, Middle East & Africa (EMEA) and transferred its Russia and Belarus operations into Asia Pacific. Historical segment figures for FY2023–FY2025 are recast per Form 8-K filed March 17, 2026; legacy Europe and Africa/Eurasia series are preserved through Q4 2025.
- ASC 280 significant segment expenses: segment-level Cost of Sales, Selling, General & Administrative (SG&A) expenses, and Other (income) expense, net are sourced from the Segment Information footnote and the October 2024 and March 2026 Form 8-K recasts.
- All percentages, basis-point margin bridges, and growth rates are as reported by the company. The only computed cells are period detachments (Q4 = full year minus nine months; quarterly cash flow = year-to-date minus prior year-to-date), displayed in italics with their formula.
- Colgate-Palmolive (India) Limited (NSE: COLPAL / BSE: 500830) is a 51%-owned, publicly listed Indian subsidiary; its self-reported financial, operational cost (including parent royalty and freight), and assured BRSR sustainability metrics are reported in INR Lakhs (Indian fiscal year ended March 31 mapped to the preceding calendar year).
- No consolidated minus parent-only calculation is performed because Colgate-Palmolive reports under U.S. GAAP without standalone parent-only financial statements.
Không hiện vì thiếu các kỳ gần đây (25)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Gross Profit Margin YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Gross Profit Margin YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › North America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › North America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment SG&A Expense Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › North America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Latin America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Advertising Investment Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › North America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Latin America
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Europe, Middle East & Africa (EMEA)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Europe (Legacy Structure)
- 3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets › Segment Overhead Expense Ratio YoY Change (bps, MD&A) › Africa/Eurasia (Legacy Structure)
- 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP Gross Profit Margin YoY Change (bps)
- 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps) › Advertising Investment Impact on SG&A Ratio YoY (bps)
- 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps) › Overhead Expense Impact on SG&A Ratio YoY (bps)
- 4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results › Base Business (Non-GAAP) Income Before Income Taxes ($M) › Base Business Non-Service Postretirement Costs ($M)
Dữ liệu cập nhật 2026-11-04.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
1. Global Oral Care Market Share & Product Category Sales Mix
2. Organic Sales Growth & Volume / Pricing / Foreign Exchange Decomposition by Division
- Organic Sales Growth YoY (%) (%)44 kỳ
- Organic Volume Change YoY (%) (%)44 kỳ
- As-Reported Volume Change YoY (Including Acquisitions & Divestments, %) (%)44 kỳ
- Net Selling Price Change YoY (Pricing, Coupons & Trade Incentives, %) (%)44 kỳ
- Foreign Exchange Impact on Net Sales YoY (%) (%)44 kỳ
- As-Reported Net Sales Growth YoY (%) (%)44 kỳ
- Segment Operating Profit Growth YoY (%) (%)0 kỳ
3. Reportable Operating Segments P&L, Significant Expenses (ASC 280), Margin Bridges & Assets
- Net Sales by Reportable Operating Segment ($M) ($M)48 kỳ
- Cost of Sales by Reportable Operating Segment (ASC 280 Significant Expense, $M) ($M)0 kỳ
- Selling, General & Administrative Expenses by Segment (ASC 280 Significant Expense, $M) ($M)0 kỳ
- Other (Income) Expense, Net by Operating Segment (ASC 280, $M) ($M)0 kỳ
- Operating Profit by Reportable Operating Segment ($M) ($M)47 kỳ
- Operating Profit Margin by Operating Segment (% of Segment Net Sales) (%)47 kỳ
- Operating Profit Margin YoY Change by Operating Segment (bps) (bps)42 kỳ
- Segment Gross Profit Margin YoY Change (bps, MD&A) (bps)0 kỳ
- Segment Funding-the-Growth Productivity Savings Impact on Gross Margin (bps, MD&A) (bps)0 kỳ
- Segment Raw & Packaging Material Cost Impact on Gross Margin (bps, MD&A) (bps)0 kỳ
- Segment SG&A Expense Ratio YoY Change (bps, MD&A) (bps)0 kỳ
- Segment Advertising Investment Ratio YoY Change (bps, MD&A) (bps)0 kỳ
- Segment Overhead Expense Ratio YoY Change (bps, MD&A) (bps)0 kỳ
- Capital Expenditures by Reportable Operating Segment ($M) ($M)13 kỳ
- Depreciation & Amortization by Reportable Operating Segment ($M) ($M)13 kỳ
- Geographic Long-Lived Assets — Consolidated Total ($M) ($M)7 kỳ
- Identifiable Assets by Reportable Operating Segment (Legacy Disclosure through FY2023, $M) ($M)11 kỳ
4. Consolidated Margin Basis-Point Bridges, Advertising Investment & Base Business (Non-GAAP) Results
- Consolidated GAAP Gross Profit Margin YoY Change (bps) (bps)0 kỳ
- Consolidated GAAP SG&A Expense % of Net Sales YoY Change (bps) (bps)29 kỳ
- Worldwide Advertising Investment ($M) ($M)30 kỳ
- Base Business (Non-GAAP) Gross Profit ($M) ($M)74 kỳ
- Base Business (Non-GAAP) Gross Profit Margin (% of Net Sales) (%)48 kỳ
- Base Business (Non-GAAP) SG&A Expenses ($M) ($M)46 kỳ
- Base Business (Non-GAAP) Operating Profit ($M) ($M)48 kỳ
- Base Business (Non-GAAP) Operating Profit Margin (% of Net Sales) (%)48 kỳ
- Base Business (Non-GAAP) Income Before Income Taxes ($M) ($M)44 kỳ
- Base Business (Non-GAAP) Net Income Attributable to Colgate-Palmolive ($M) ($M)44 kỳ
- Base Business (Non-GAAP) Diluted Earnings Per Share ($) ($)44 kỳ
5. Monthly & Quarterly Share Repurchases, Free Cash Flow Before Dividends, Liquidity & Restructuring
6. Manufacturing Footprint, Workforce Demographics, Compensation, Customer Concentration & Supply Chain
- Total Manufacturing, Distribution, Research & Office Properties Worldwide (sites)6 kỳ
- Global Workforce Headcount (employees)6 kỳ
- CEO Total Annual Compensation ($, DEF 14A Pay Ratio Disclosure) ($)8 kỳ
- Walmart Inc. & Affiliates Share of Consolidated Net Sales (%) (%)5 kỳ
- Common Shareholders of Record at Year-End (accounts)5 kỳ
- Pending U.S. Talc Personal Injury Lawsuits at Year-End (cases)7 kỳ
- 3TG Conflict Minerals Supplier Survey Response Rate (%) (%)9 kỳ
7. Publicly Listed Subsidiary: Colgate-Palmolive (India) Limited (NSE: COLPAL, 51% Owned)
- Colgate India — Product Sales, Net of GST (INR Lakhs) (M)5 kỳ
- Colgate India — Total Revenue from Operations (INR Lakhs) (M)5 kỳ
- Colgate India — Total Operating Expenses (INR Lakhs) (M)5 kỳ
- Colgate India — Net Profit After Tax (INR Lakhs) (M)5 kỳ
- Colgate India — Total Employees Including Contractual Staff (people)4 kỳ
- Colgate India — Total Manufacturing Energy Consumed (GJ)4 kỳ
- Colgate India — Total Water Withdrawal Across Manufacturing Plants (kiloliters)5 kỳ
- Colgate India — Scope 1 Direct Greenhouse Gas Emissions (tCO2e)4 kỳ
8. External Consumer Staples Retail Price & Raw Material Input Benchmarks (BLS CPI / PPI & IMF)
- U.S. CPI: Personal Care Products (1982–84 = 100) (×)128 kỳ
- U.S. CPI: Dental Services (1982–84 = 100) (×)128 kỳ
- U.S. CPI: Household Furnishings and Operations (1982–84 = 100) (×)128 kỳ
- U.S. PPI: Cosmetics & Toilet Preparations incl. Toothpaste/Oral Care (1982 = 100) (×)129 kỳ
- U.S. PPI: Soaps and Synthetic Detergents (1982 = 100) (×)129 kỳ
- U.S. PPI: Dog and Cat Food Manufacturing (1985 = 100) (×)129 kỳ
- U.S. PPI: Plastic Resins and Materials — Packaging Input (1982 = 100) (×)129 kỳ
- Global Price of Palm Oil — Key Oleochemical Raw Material ($ / metric ton) ($)129 kỳ
- Global Price of Brent Crude Oil — Packaging & Logistics Benchmark ($ / barrel) ($)129 kỳ
9. Consolidated Financial Statements Baseline (SEC Form 10-K / Form 10-Q)
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Colgate Palmolive
- Earnings Release (Form 8-K Exhibit 99), filed 2026-10-30 ↗
- Earnings Release (Form 8-K Exhibit 99), filed 2026-01-30 ↗
- Form 10-Q Quarterly Report, filed 2026-10-30 ↗
- Form 10-K Annual Report, filed 2026-02-23 ↗
- Colgate-Palmolive (India) Limited Unaudited Financial Results for Q2 FY2026-27 (Ended September 30, 2026) ↗
- Form 10-Q Quarterly Report, filed 2026-10-30 ↗
- Form 10-K Annual Report, filed 2026-02-23 ↗
- Colgate-Palmolive (India) Limited Integrated Annual & BRSR Report FY2025-26 ↗
- Form 8-K (EMEA & Asia Pacific Segment Information Recast), filed 2026-03-17 ↗
- Form 8-K Exhibit 99.2 (ASC 280 Segment Expense Recast), filed 2024-10-25 ↗
- Definitive Proxy Statement (DEF 14A), filed 2026-03-25 ↗
- Form SD Conflict Minerals Report, filed 2026-06-01 ↗
See a number that looks wrong?